| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Capsule Endoscopy | 6 | 2018 | 75 | 2.96 | Why? |
| Foreign Bodies | 6 | 2020 | 171 | 2.93 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 6 | 2018 | 237 | 2.55 | Why? |
| Anal Canal | 5 | 2018 | 367 | 2.31 | Why? |
| Gastrointestinal Hemorrhage | 6 | 2018 | 669 | 2.29 | Why? |
| Jejunum | 4 | 2018 | 82 | 2.23 | Why? |
| Colonoscopy | 9 | 2019 | 738 | 2.16 | Why? |
| Endosonography | 5 | 2018 | 150 | 2.07 | Why? |
| Esophagus | 5 | 2017 | 139 | 2.04 | Why? |
| Granuloma | 3 | 2019 | 88 | 2.03 | Why? |
| Endoscopy, Digestive System | 5 | 2021 | 352 | 2.00 | Why? |
| Intestinal Obstruction | 3 | 2018 | 197 | 1.76 | Why? |
| Stents | 5 | 2018 | 916 | 1.74 | Why? |
| Pancreatic Neoplasms | 4 | 2018 | 609 | 1.65 | Why? |
| Esophageal Diseases | 3 | 2017 | 34 | 1.61 | Why? |
| Endoscopy, Gastrointestinal | 7 | 2021 | 1545 | 1.59 | Why? |
| Crohn Disease | 6 | 2018 | 959 | 1.52 | Why? |
| Meckel Diverticulum | 2 | 2018 | 6 | 1.51 | Why? |
| Colon | 5 | 2018 | 669 | 1.49 | Why? |
| Hyperplasia | 3 | 2018 | 204 | 1.48 | Why? |
| Liver Diseases | 8 | 2021 | 2698 | 1.43 | Why? |
| Biliary Tract Diseases | 2 | 2019 | 60 | 1.43 | Why? |
| Anus Neoplasms | 3 | 2018 | 123 | 1.42 | Why? |
| Dilatation | 4 | 2017 | 181 | 1.41 | Why? |
| Gastritis | 2 | 2017 | 66 | 1.39 | Why? |
| Pancreatic Ducts | 2 | 2017 | 29 | 1.39 | Why? |
| Colorectal Neoplasms | 5 | 2019 | 1884 | 1.35 | Why? |
| Precancerous Conditions | 2 | 2019 | 108 | 1.35 | Why? |
| Esophageal Achalasia | 2 | 2017 | 30 | 1.32 | Why? |
| Rectal Diseases | 2 | 2017 | 111 | 1.24 | Why? |
| Enteritis | 2 | 2017 | 147 | 1.23 | Why? |
| Ileum | 3 | 2018 | 233 | 1.23 | Why? |
| Pancreatic Diseases | 2 | 2019 | 191 | 1.21 | Why? |
| Gastroenterology | 4 | 2021 | 1352 | 1.20 | Why? |
| Gastroenterologists | 2 | 2021 | 259 | 1.19 | Why? |
| Gastroscopy | 2 | 2017 | 112 | 1.19 | Why? |
| Liver Neoplasms | 4 | 2019 | 1666 | 1.19 | Why? |
| Bile Duct Neoplasms | 2 | 2019 | 172 | 1.18 | Why? |
| Colitis, Ulcerative | 5 | 2018 | 1037 | 1.16 | Why? |
| Deglutition Disorders | 5 | 2018 | 481 | 1.13 | Why? |
| Esophageal Neoplasms | 3 | 2018 | 357 | 1.09 | Why? |
| Celiac Disease | 2 | 2021 | 471 | 1.06 | Why? |
| Anastomosis, Surgical | 4 | 2018 | 169 | 1.06 | Why? |
| Carcinoma, Hepatocellular | 3 | 2019 | 1222 | 1.04 | Why? |
| Adenocarcinoma | 4 | 2017 | 651 | 1.02 | Why? |
| Abdominal Pain | 2 | 2018 | 858 | 0.94 | Why? |
| Postoperative Complications | 5 | 2018 | 5861 | 0.91 | Why? |
| Ischemia | 3 | 2022 | 901 | 0.90 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2018 | 75 | 0.90 | Why? |
| Cytodiagnosis | 2 | 2019 | 104 | 0.83 | Why? |
| Duodenum | 2 | 2018 | 179 | 0.80 | Why? |
| Tumor Necrosis Factor-alpha | 4 | 2019 | 2483 | 0.80 | Why? |
| Stomach | 1 | 2020 | 141 | 0.79 | Why? |
| Esophagoscopy | 5 | 2017 | 95 | 0.78 | Why? |
| Taeniasis | 1 | 2018 | 9 | 0.77 | Why? |
| Proctitis | 1 | 2018 | 16 | 0.77 | Why? |
| Ileocecal Valve | 1 | 2018 | 1 | 0.76 | Why? |
| Intestinal Fistula | 1 | 2019 | 43 | 0.76 | Why? |
| Intestinal Polyps | 1 | 2018 | 11 | 0.75 | Why? |
| Transition to Adult Care | 1 | 2019 | 56 | 0.75 | Why? |
| Inflammatory Bowel Diseases | 5 | 2020 | 3209 | 0.75 | Why? |
| Appendix | 1 | 2018 | 10 | 0.74 | Why? |
| Patient Handoff | 1 | 2019 | 68 | 0.74 | Why? |
| Equipment Failure | 1 | 2020 | 197 | 0.73 | Why? |
| Pancreatic Cyst | 1 | 2018 | 11 | 0.73 | Why? |
| Nail Biting | 1 | 2017 | 6 | 0.72 | Why? |
| Cavernous Sinus | 1 | 2017 | 5 | 0.72 | Why? |
| Anastomotic Leak | 1 | 2018 | 46 | 0.72 | Why? |
| Carcinoma in Situ | 1 | 2018 | 58 | 0.72 | Why? |
| Self Expandable Metallic Stents | 1 | 2018 | 52 | 0.72 | Why? |
| Paraganglioma | 1 | 2017 | 33 | 0.72 | Why? |
| Diverticulitis | 1 | 2018 | 65 | 0.72 | Why? |
| Proctocolitis | 1 | 2017 | 2 | 0.72 | Why? |
| Ascariasis | 1 | 2017 | 21 | 0.72 | Why? |
| Fecal Impaction | 1 | 2017 | 4 | 0.72 | Why? |
| Duodenal Neoplasms | 1 | 2017 | 24 | 0.71 | Why? |
| Brunner Glands | 1 | 2017 | 1 | 0.71 | Why? |
| Jejunal Diseases | 1 | 2017 | 29 | 0.71 | Why? |
| Esophageal Fistula | 1 | 2017 | 11 | 0.71 | Why? |
| Perivascular Epithelioid Cell Neoplasms | 1 | 2017 | 3 | 0.71 | Why? |
| Proctoscopy | 1 | 2017 | 28 | 0.70 | Why? |
| Ileal Diseases | 1 | 2018 | 47 | 0.70 | Why? |
| Sebaceous Glands | 1 | 2017 | 9 | 0.70 | Why? |
| Neurilemmoma | 1 | 2017 | 17 | 0.70 | Why? |
| Duodenal Diseases | 1 | 2017 | 30 | 0.70 | Why? |
| Sphenoid Sinus | 1 | 2017 | 26 | 0.70 | Why? |
| Intraabdominal Infections | 1 | 2018 | 90 | 0.70 | Why? |
| Pyloromyotomy | 1 | 2017 | 1 | 0.70 | Why? |
| Pylorus | 1 | 2017 | 2 | 0.70 | Why? |
| Ampulla of Vater | 1 | 2017 | 17 | 0.70 | Why? |
| Pancreatitis, Chronic | 1 | 2017 | 37 | 0.69 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2017 | 27 | 0.69 | Why? |
| Vascular Fistula | 1 | 2017 | 22 | 0.69 | Why? |
| Constriction, Pathologic | 2 | 2017 | 212 | 0.69 | Why? |
| Entamoebiasis | 1 | 2017 | 10 | 0.69 | Why? |
| Anorexia | 1 | 2018 | 194 | 0.69 | Why? |
| Hamartoma | 1 | 2017 | 21 | 0.69 | Why? |
| Dyspepsia | 1 | 2017 | 60 | 0.69 | Why? |
| Choristoma | 1 | 2017 | 16 | 0.68 | Why? |
| Etanercept | 1 | 2019 | 162 | 0.68 | Why? |
| Esophageal Stenosis | 1 | 2017 | 21 | 0.68 | Why? |
| Entamoeba histolytica | 1 | 2017 | 22 | 0.68 | Why? |
| Jejunostomy | 1 | 2016 | 8 | 0.68 | Why? |
| Ampicillin | 1 | 2017 | 73 | 0.68 | Why? |
| Giardiasis | 1 | 2017 | 34 | 0.68 | Why? |
| Leishmaniasis, Visceral | 1 | 2018 | 85 | 0.67 | Why? |
| Fecal Incontinence | 1 | 2017 | 40 | 0.67 | Why? |
| Bile Ducts | 1 | 2017 | 84 | 0.67 | Why? |
| Lymphoid Tissue | 1 | 2018 | 162 | 0.67 | Why? |
| Pneumatosis Cystoides Intestinalis | 1 | 2017 | 41 | 0.66 | Why? |
| Gastroparesis | 1 | 2017 | 29 | 0.66 | Why? |
| Manometry | 1 | 2017 | 91 | 0.66 | Why? |
| Paranasal Sinus Neoplasms | 1 | 2017 | 55 | 0.66 | Why? |
| Rectum | 2 | 2017 | 495 | 0.65 | Why? |
| Listeria monocytogenes | 1 | 2017 | 68 | 0.65 | Why? |
| Hemostasis, Endoscopic | 1 | 2016 | 24 | 0.65 | Why? |
| Endoscopic Mucosal Resection | 1 | 2017 | 63 | 0.65 | Why? |
| Infliximab | 2 | 2018 | 502 | 0.65 | Why? |
| Azathioprine | 2 | 2017 | 161 | 0.65 | Why? |
| Catheters | 1 | 2017 | 93 | 0.64 | Why? |
| Endoscopes | 1 | 2017 | 72 | 0.64 | Why? |
| Ligation | 1 | 2016 | 84 | 0.64 | Why? |
| Carcinoma, Papillary | 1 | 2017 | 76 | 0.64 | Why? |
| Gastrointestinal Agents | 2 | 2018 | 393 | 0.64 | Why? |
| Diabetic Neuropathies | 1 | 2017 | 64 | 0.63 | Why? |
| Gastrostomy | 1 | 2016 | 56 | 0.63 | Why? |
| Hepatitis | 1 | 2019 | 160 | 0.63 | Why? |
| Cholangitis | 1 | 2017 | 81 | 0.62 | Why? |
| Adenoma | 1 | 2019 | 215 | 0.62 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 112 | 0.62 | Why? |
| Roseolovirus Infections | 1 | 2017 | 131 | 0.62 | Why? |
| Acute-On-Chronic Liver Failure | 1 | 2019 | 237 | 0.62 | Why? |
| Endoscopy | 4 | 2020 | 1564 | 0.62 | Why? |
| Colonic Polyps | 1 | 2018 | 117 | 0.62 | Why? |
| Heart Neoplasms | 1 | 2017 | 77 | 0.62 | Why? |
| Deglutition | 1 | 2016 | 104 | 0.61 | Why? |
| Lymphoproliferative Disorders | 1 | 2017 | 110 | 0.61 | Why? |
| Colonic Diseases | 1 | 2017 | 96 | 0.60 | Why? |
| Q Fever | 1 | 2017 | 130 | 0.60 | Why? |
| Remission Induction | 1 | 2019 | 950 | 0.60 | Why? |
| Carcinoma, Squamous Cell | 3 | 2019 | 902 | 0.60 | Why? |
| Metals | 1 | 2017 | 182 | 0.59 | Why? |
| Pemphigoid, Bullous | 1 | 2017 | 89 | 0.59 | Why? |
| Liver Cirrhosis | 4 | 2020 | 1810 | 0.59 | Why? |
| Equipment Safety | 1 | 2016 | 167 | 0.58 | Why? |
| Mesenteric Ischemia | 1 | 2017 | 128 | 0.58 | Why? |
| Esophageal and Gastric Varices | 1 | 2016 | 117 | 0.57 | Why? |
| Peritonitis | 1 | 2017 | 217 | 0.56 | Why? |
| Bone and Bones | 1 | 2017 | 235 | 0.56 | Why? |
| Eating | 1 | 2017 | 395 | 0.56 | Why? |
| Cholecystitis, Acute | 1 | 2017 | 234 | 0.55 | Why? |
| Cholangiocarcinoma | 1 | 2016 | 186 | 0.54 | Why? |
| Humans | 93 | 2022 | 930598 | 0.54 | Why? |
| Erythema | 1 | 2018 | 400 | 0.54 | Why? |
| Lymphoma, B-Cell, Marginal Zone | 1 | 2013 | 44 | 0.53 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2019 | 451 | 0.53 | Why? |
| Leukemic Infiltration | 1 | 2013 | 9 | 0.53 | Why? |
| Portugal | 4 | 2021 | 1265 | 0.52 | Why? |
| Male | 53 | 2022 | 367725 | 0.52 | Why? |
| Antirheumatic Agents | 2 | 2019 | 3023 | 0.51 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2021 | 1316 | 0.51 | Why? |
| Drug Eruptions | 1 | 2018 | 319 | 0.50 | Why? |
| Incidental Findings | 1 | 2017 | 487 | 0.50 | Why? |
| Epstein-Barr Virus Infections | 1 | 2017 | 366 | 0.50 | Why? |
| Glomerular Filtration Rate | 1 | 2019 | 1262 | 0.50 | Why? |
| Hematoma | 1 | 2016 | 305 | 0.49 | Why? |
| Candidiasis | 1 | 2017 | 334 | 0.49 | Why? |
| Aortic Diseases | 1 | 2017 | 362 | 0.49 | Why? |
| Intestines | 1 | 2019 | 817 | 0.48 | Why? |
| Emergency Treatment | 1 | 2018 | 719 | 0.47 | Why? |
| Stomach Neoplasms | 2 | 2017 | 477 | 0.46 | Why? |
| Muscular Diseases | 1 | 2017 | 392 | 0.45 | Why? |
| Radiotherapy | 1 | 2016 | 608 | 0.44 | Why? |
| Nasal Cavity | 1 | 2017 | 909 | 0.44 | Why? |
| Diagnosis, Differential | 7 | 2018 | 7220 | 0.43 | Why? |
| Radiation Dosage | 1 | 2015 | 585 | 0.43 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.42 | Why? |
| Female | 44 | 2021 | 380317 | 0.40 | Why? |
| Colectomy | 3 | 2017 | 327 | 0.39 | Why? |
| Early Detection of Cancer | 2 | 2018 | 1956 | 0.39 | Why? |
| Middle Aged | 34 | 2022 | 270681 | 0.39 | Why? |
| Adult | 32 | 2021 | 244371 | 0.37 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.36 | Why? |
| Vascular Diseases | 1 | 2017 | 846 | 0.36 | Why? |
| Aged | 28 | 2019 | 215776 | 0.36 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 9706 | 0.35 | Why? |
| Videoconferencing | 1 | 2020 | 2081 | 0.34 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.34 | Why? |
| Kidney Transplantation | 2 | 2018 | 5397 | 0.34 | Why? |
| Anesthesia | 1 | 2017 | 1236 | 0.33 | Why? |
| Catheterization | 3 | 2017 | 264 | 0.32 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.31 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2013 | 676 | 0.31 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.30 | Why? |
| Liver | 2 | 2017 | 4007 | 0.29 | Why? |
| Arthritis, Rheumatoid | 1 | 2019 | 2043 | 0.29 | Why? |
| Tomography, X-Ray Computed | 8 | 2018 | 25144 | 0.28 | Why? |
| Ulcer | 1 | 2006 | 128 | 0.28 | Why? |
| Immunocompromised Host | 2 | 2021 | 5150 | 0.27 | Why? |
| Treatment Outcome | 10 | 2018 | 51732 | 0.26 | Why? |
| Pediatrics | 1 | 2019 | 2969 | 0.26 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.25 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 5002 | 0.25 | Why? |
| Practice Patterns, Physicians' | 1 | 2021 | 4927 | 0.23 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.23 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.23 | Why? |
| Heart Failure | 2 | 2020 | 6638 | 0.22 | Why? |
| Immunosuppressive Agents | 2 | 2017 | 6331 | 0.22 | Why? |
| Fever | 1 | 2018 | 7795 | 0.22 | Why? |
| Anti-Bacterial Agents | 3 | 2017 | 10083 | 0.21 | Why? |
| Biopsy | 3 | 2018 | 2811 | 0.21 | Why? |
| Mental Fatigue | 1 | 2020 | 48 | 0.21 | Why? |
| Respiratory Insufficiency | 1 | 2022 | 7301 | 0.21 | Why? |
| Double-Balloon Enteroscopy | 1 | 2018 | 2 | 0.20 | Why? |
| Taenia saginata | 1 | 2018 | 5 | 0.20 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2019 | 40 | 0.19 | Why? |
| Retrospective Studies | 10 | 2019 | 105322 | 0.19 | Why? |
| Anticestodal Agents | 1 | 2018 | 10 | 0.19 | Why? |
| Albendazole | 1 | 2018 | 32 | 0.19 | Why? |
| Melena | 1 | 2018 | 30 | 0.19 | Why? |
| Leishmania infantum | 1 | 2018 | 29 | 0.19 | Why? |
| Foreign-Body Migration | 1 | 2018 | 25 | 0.18 | Why? |
| Asthenia | 1 | 2018 | 107 | 0.18 | Why? |
| Ascaris lumbricoides | 1 | 2017 | 11 | 0.18 | Why? |
| Surgical Instruments | 1 | 2019 | 145 | 0.18 | Why? |
| Rectocele | 1 | 2017 | 7 | 0.18 | Why? |
| Time Factors | 5 | 2019 | 31397 | 0.18 | Why? |
| Paracentesis | 1 | 2017 | 25 | 0.18 | Why? |
| Antitrichomonal Agents | 1 | 2017 | 1 | 0.17 | Why? |
| Sclerosis | 1 | 2017 | 26 | 0.17 | Why? |
| Blepharoptosis | 1 | 2017 | 31 | 0.17 | Why? |
| Sigmoidoscopy | 1 | 2017 | 50 | 0.17 | Why? |
| Gastric Emptying | 1 | 2017 | 9 | 0.17 | Why? |
| Anastomosis, Roux-en-Y | 1 | 2016 | 24 | 0.17 | Why? |
| Mathematical Concepts | 1 | 2019 | 370 | 0.17 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2017 | 9335 | 0.17 | Why? |
| Respiratory Aspiration | 1 | 2016 | 23 | 0.17 | Why? |
| Learning Curve | 1 | 2018 | 157 | 0.17 | Why? |
| Metronidazole | 1 | 2017 | 59 | 0.17 | Why? |
| Gastric Outlet Obstruction | 1 | 2016 | 14 | 0.17 | Why? |
| Fishes | 1 | 2017 | 99 | 0.16 | Why? |
| Glomerulonephritis, IGA | 1 | 2018 | 115 | 0.16 | Why? |
| Drug Administration Routes | 1 | 2016 | 106 | 0.16 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.16 | Why? |
| Bile Ducts, Intrahepatic | 1 | 2016 | 68 | 0.16 | Why? |
| Magnetic Resonance Imaging | 3 | 2017 | 6551 | 0.16 | Why? |
| Antibodies, Monoclonal | 1 | 2015 | 8041 | 0.16 | Why? |
| Cerebral Palsy | 1 | 2017 | 156 | 0.15 | Why? |
| Laparoscopy | 2 | 2018 | 1532 | 0.15 | Why? |
| Tertiary Care Centers | 3 | 2018 | 8248 | 0.15 | Why? |
| Intussusception | 1 | 2017 | 102 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.15 | Why? |
| Nails | 1 | 2017 | 143 | 0.15 | Why? |
| Gastrectomy | 1 | 2017 | 225 | 0.15 | Why? |
| Radionuclide Imaging | 1 | 2017 | 184 | 0.15 | Why? |
| Radiation Exposure | 1 | 2017 | 161 | 0.15 | Why? |
| Herpesvirus 6, Human | 1 | 2017 | 162 | 0.15 | Why? |
| Cholecystectomy | 1 | 2017 | 198 | 0.15 | Why? |
| Aged, 80 and over | 7 | 2018 | 88759 | 0.15 | Why? |
| Device Removal | 1 | 2017 | 221 | 0.15 | Why? |
| Giant Cells | 1 | 2017 | 334 | 0.14 | Why? |
| Radiation Injuries | 1 | 2016 | 140 | 0.14 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.14 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.14 | Why? |
| Young Adult | 7 | 2018 | 93724 | 0.14 | Why? |
| Anemia, Iron-Deficiency | 1 | 2017 | 210 | 0.14 | Why? |
| Intubation | 1 | 2017 | 437 | 0.14 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.14 | Why? |
| Helicobacter Infections | 1 | 2017 | 216 | 0.14 | Why? |
| Doxycycline | 1 | 2017 | 307 | 0.14 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.14 | Why? |
| Helicobacter pylori | 1 | 2017 | 262 | 0.14 | Why? |
| Antibiotic Prophylaxis | 1 | 2017 | 399 | 0.14 | Why? |
| Drug Therapy | 1 | 2016 | 280 | 0.13 | Why? |
| Acute Disease | 2 | 2017 | 6029 | 0.13 | Why? |
| Herpesvirus 4, Human | 1 | 2017 | 387 | 0.13 | Why? |
| Enteral Nutrition | 1 | 2017 | 320 | 0.13 | Why? |
| Adalimumab | 1 | 2018 | 389 | 0.13 | Why? |
| Drainage | 1 | 2017 | 414 | 0.13 | Why? |
| Plastics | 1 | 2017 | 463 | 0.13 | Why? |
| Mass Screening | 3 | 2018 | 8005 | 0.13 | Why? |
| Decision Support Techniques | 1 | 2021 | 903 | 0.13 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.13 | Why? |
| Conservative Treatment | 1 | 2016 | 349 | 0.13 | Why? |
| Quality Assurance, Health Care | 1 | 2018 | 596 | 0.12 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.12 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.12 | Why? |
| Interprofessional Relations | 1 | 2020 | 1013 | 0.12 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.12 | Why? |
| Self-Injurious Behavior | 1 | 2017 | 391 | 0.12 | Why? |
| Hepatitis, Autoimmune | 1 | 2016 | 254 | 0.12 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.12 | Why? |
| Hepatitis A | 1 | 1994 | 140 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2017 | 600 | 0.12 | Why? |
| Colonic Neoplasms | 1 | 2016 | 295 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Recurrence | 2 | 2017 | 3675 | 0.11 | Why? |
| Purpura | 1 | 1994 | 310 | 0.10 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.10 | Why? |
| Physician-Patient Relations | 1 | 2020 | 1266 | 0.10 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.10 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.10 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.09 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.09 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.09 | Why? |
| Cystic Fibrosis | 1 | 2018 | 1104 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Bacteria | 1 | 2019 | 1897 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Radiography | 1 | 2015 | 1576 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.08 | Why? |
| Computed Tomography Angiography | 1 | 2017 | 2153 | 0.08 | Why? |
| Lung Transplantation | 1 | 2018 | 1554 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.08 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.08 | Why? |
| New York City | 1 | 2020 | 7432 | 0.08 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.08 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.08 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.08 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.08 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.08 | Why? |
| Patient Safety | 1 | 2021 | 4885 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Nurses | 1 | 2021 | 2285 | 0.07 | Why? |
| Asymptomatic Diseases | 1 | 2017 | 3444 | 0.07 | Why? |
| Occupational Health | 1 | 2021 | 3965 | 0.07 | Why? |
| Burnout, Professional | 1 | 2020 | 2489 | 0.07 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.07 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.07 | Why? |
| Animals | 3 | 2018 | 78931 | 0.07 | Why? |
| Feces | 1 | 2017 | 4235 | 0.06 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2019 | 3550 | 0.06 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Palliative Care | 1 | 2017 | 2665 | 0.06 | Why? |
| Europe | 1 | 2019 | 12702 | 0.06 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.06 | Why? |
| Physicians | 1 | 2021 | 4214 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.05 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.05 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.05 | Why? |
| Colonoscopes | 1 | 2017 | 9 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.05 | Why? |
| Glutathione Peroxidase | 1 | 2017 | 83 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.04 | Why? |
| Superoxide Dismutase | 1 | 2017 | 155 | 0.04 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2017 | 238 | 0.04 | Why? |
| Lactoferrin | 1 | 2017 | 208 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.04 | Why? |
| Mycophenolic Acid | 1 | 2016 | 383 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2019 | 21571 | 0.03 | Why? |
| Budesonide | 1 | 2016 | 192 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.03 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| Tacrolimus | 1 | 2016 | 435 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Cyclosporine | 1 | 2016 | 449 | 0.03 | Why? |
| Methyltransferases | 1 | 2016 | 720 | 0.03 | Why? |
| Rituximab | 1 | 2016 | 1096 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.02 | Why? |
| Health Care Surveys | 1 | 2016 | 2942 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |